Browse the evidence

Traditional foods contributed almost half of participants' energy intake.

Practitioners should consider the role of traditional foods in the diets of Hispanic immigrant men.

Few significant correlations were found between acculturation and nutrient intake.

Practitioners may need to consider that acculturation does not significantly influence nutrient intake in this population.

The agreement (Cohen's κ) between the different combinations of variables used to ascertain sarcopenia status was below .50.

Clinicians should be cautious in interpreting sarcopenia status due to the lack of agreement among assessment methods.

The combination of variables used to ascertain sarcopenia and many of the ALM adjustment techniques have insufficient agreement to be considered equivalent.

A unified definition of sarcopenia is needed for consistent clinical assessment.

To improve the clinical utility of sarcopenia, a unified definition of sarcopenia is required.

Standardizing sarcopenia definitions could lead to better management and treatment outcomes.

There were no significant age-by-resilience interactions found.

Diet quality's impact on resilience appears consistent across different adult age groups.

There is no consistent association between entrée price and Estimated Nutrition Score (ENS) in the sample assessed.

Customers can often choose healthier entrées that are priced less than or equal to less healthy entrées.

More healthy options were more expensive at 2 out of 6 restaurants where a significant association between ENS and price was found.

Practitioners should be aware that not all healthier options are cheaper, as some may be priced higher.

Mean WELL Diet Scores were highest in the oldest age group.

Older adults may benefit from dietary interventions aimed at improving diet quality.

71% of obese individuals, 54% of overweight individuals, and only 10% of underweight individuals are 'very likely' to participate in a weight management program.

Practitioners should focus on targeting overweight and obese military dependents for weight management programs.

The overall prevalence of sarcopenia in the studied population is 6.42%.

Practitioners should be aware of the prevalence of sarcopenia in older adults in urban-rural transition zones.

A long-term farming history is a strong, independent protective factor against sarcopenia.

Encouraging a farming lifestyle may help reduce sarcopenia risk in older adults.

The association between diabetes and sarcopenia was not statistically significant after adjusting for confounders.

Diabetes may not be a significant risk factor for sarcopenia when considering other factors.

Obesity was associated with diabetes only in the urban population.

Urban health initiatives should focus on obesity as a risk factor for diabetes.

Amateur weightlifters and bodybuilders are a new risk group for developing dental caries.

Awareness and preventive measures should be implemented for this group to mitigate dental health risks.

Methods of oral hygiene reported by participants appear to be insufficient.

Improving oral hygiene practices is crucial for this population to prevent dental issues.

Greater weight loss following bariatric surgery correlates with a higher likelihood of discontinuing anti-glycemic medications, although this specific correlation was not statistically significant in this study due to sample size.

While surgery helps everyone, those who lose more weight (11-15 BMI points) are much more likely to stop taking diabetes medications than those who lose less. Aim for significant weight loss to maximize the chance of medication independence.

Weight loss in Type 2 Diabetic patients releases Persistent Organic Pollutants (POPs) from adipose tissue into circulation, which can attenuate or negate the expected cardiovascular benefits of the weight loss.

If you have Type 2 Diabetes and are losing weight, be aware that fat loss releases stored environmental chemicals (POPs) into your blood, which might temporarily offset heart health benefits. To mitigate this, focus on dietary strategies that help your body excrete these toxins, such as a plant-based diet with moderate fat and intermittent fasting, rather than just any weight loss method.

RYGB surgery leads to a conditioned avoidance of high-fat foods, where patients continue to find fat palatable ('like') but reduce consumption ('want') due to negative gastrointestinal feedback.

You may still enjoy fatty foods, but your body has likely learned to limit them through conditioning. This is a normal, healthy adaptation to surgery, not a sign of failure.

Pharmacological weight loss agents (e.g., GLP-1 agonists, Orlistat) are second-line treatments for OHS, used when lifestyle changes fail, but their efficacy is generally lower than bariatric surgery and they require careful monitoring for adverse effects.

If diet and exercise aren't enough, weight loss drugs can help. They are a second step, not a replacement for lifestyle changes. You must try them for 3 months; if you don't lose at least 5% of your body weight, stop and try a different approach or consider surgery.

Obesity increases atherosclerosis susceptibility via an endocrine-like mechanism where adipose-derived miR-30e-5p travels to vascular endothelial cells, downregulates SLC7A11, and impairs mitochondrial function.

This research highlights that obesity is not just a passive storage of fat but an active endocrine organ that sends damaging signals to blood vessels. Managing body weight is crucial to stop adipose tissue from releasing miR-30e-5p, which directly harms the lining of your arteries and promotes plaque buildup, independent of cholesterol levels.

Medical weight management (MWM) using older obesity medications and lifestyle modification does not significantly reduce the risk of major adverse cardiovascular events (MACE) compared to usual care in patients with obesity and type 2 diabetes.

If you have obesity and type 2 diabetes, using older weight loss medications (like liraglutide or exenatide) along with lifestyle changes did not significantly lower your risk of major heart events compared to standard care in this study. This does not mean the medication is useless for weight loss, but do not rely on it for heart protection. Newer medications (semaglutide, tirzepatide) might have different outcomes, but for now, focus on sustainable weight loss and managing diabetes.

Biliopancreatic Diversion (BPD) appears to be the most effective bariatric surgery for achieving T2DM remission and lowering HbA1c levels, although evidence is sparse due to limited study numbers.

Biliopancreatic Diversion (BPD) shows the strongest potential for reversing Type 2 Diabetes and significantly lowering HbA1c levels among all bariatric surgeries. However, because very few studies have evaluated it, its use is limited by concerns over surgical complexity and complications. It should be considered for patients with severe T2DM and obesity who are willing to accept higher surgical risks for the best chance of remission.

Fecal microbiota transplantation (FMT) from lean donors transiently improves insulin sensitivity and glucose metabolism in patients with metabolic syndrome, though effects often diminish after 18 weeks without maintenance.

FMT from lean donors can significantly boost insulin sensitivity and lower blood sugar in metabolic syndrome patients, but these benefits are temporary (lasting ~6 weeks) and may require repeated treatments or maintenance fiber. It is not a one-time cure and is currently expensive.